Canada markets close in 4 hours 52 minutes
  • S&P/TSX

    -83.96 (-0.42%)
  • S&P 500

    -12.70 (-0.30%)
  • DOW

    -49.01 (-0.15%)

    -0.0085 (-1.09%)

    -3.85 (-4.18%)

    -692.05 (-2.17%)
  • CMC Crypto 200

    -17.62 (-2.98%)

    -21.50 (-1.18%)
  • RUSSELL 2000

    -14.40 (-0.71%)
  • 10-Yr Bond

    -0.0720 (-2.53%)

    -30.71 (-0.24%)

    +0.85 (+4.35%)
  • FTSE

    +4.80 (+0.06%)
  • NIKKEI 225

    +324.80 (+1.14%)

    -0.0029 (-0.38%)

Further weakness as I-Mab (NASDAQ:IMAB) drops 40% this week, taking one-year losses to 76%

  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Even the best investor on earth makes unsuccessful investments. But serious investors should think long and hard about avoiding extreme losses. It must have been painful to be a I-Mab (NASDAQ:IMAB) shareholder over the last year, since the stock price plummeted 76% in that time. That'd be enough to make even the strongest stomachs churn. I-Mab hasn't been listed for long, so although we're wary of recent listings that perform poorly, it may still prove itself with time. Furthermore, it's down 75% in about a quarter. That's not much fun for holders.

After losing 40% this past week, it's worth investigating the company's fundamentals to see what we can infer from past performance.

See our latest analysis for I-Mab

Because I-Mab made a loss in the last twelve months, we think the market is probably more focussed on revenue and revenue growth, at least for now. Shareholders of unprofitable companies usually expect strong revenue growth. That's because it's hard to be confident a company will be sustainable if revenue growth is negligible, and it never makes a profit.

In the last year I-Mab saw its revenue grow by 10,303%. That's a strong result which is better than most other loss making companies. So on the face of it we're really surprised to see the share price down 76% over twelve months. There's clearly something unusual going on here such as an acquisition that hasn't delivered expected profits. We'd recommend taking a very close look at the stock (and any available forecasts), before considering a purchase, because the share price is not correlated with the revenue growth, that's for sure. Of course, markets do over-react so share price drop may be too harsh.

The company's revenue and earnings (over time) are depicted in the image below (click to see the exact numbers).


I-Mab is well known by investors, and plenty of clever analysts have tried to predict the future profit levels. So it makes a lot of sense to check out what analysts think I-Mab will earn in the future (free analyst consensus estimates)

A Different Perspective

I-Mab shareholders are down 76% for the year, even worse than the market loss of 3.8%. There's no doubt that's a disappointment, but the stock may well have fared better in a stronger market. The share price decline has continued throughout the most recent three months, down 75%, suggesting an absence of enthusiasm from investors. Basically, most investors should be wary of buying into a poor-performing stock, unless the business itself has clearly improved. It's always interesting to track share price performance over the longer term. But to understand I-Mab better, we need to consider many other factors. For example, we've discovered 3 warning signs for I-Mab that you should be aware of before investing here.

For those who like to find winning investments this free list of growing companies with recent insider purchasing, could be just the ticket.

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on US exchanges.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at)

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting